Rohto Pharmaceutical (4527) Investor presentation summary

Management vision and strategy

• Articulates a medium- to long-term vision focused on well-being, longevity, and enhancing corporate value through innovation and regular strategic reviews.

• Corporate philosophy centers on contributing to mental and physical health, solving social issues, and sharing benefits with stakeholders.

• Emphasizes a rolling approach to management forecasts to adapt to rapid environmental changes.

Business portfolio and market position

• Maintains leading market shares in Japan and Asia across eye care, skin care, and internal medicine/food categories.

• Reinvests cash from core businesses into high-growth areas like medical and regenerative medicine.

• Expands globally, especially in Asia and Europe, through strategic M&A and brand leverage.

Innovation, R&D, and intellectual property

• Integrates expertise across eye care, skin care, internal medicine, and regenerative medicine to drive longevity science.

• Holds top patent positions in ophthalmic drugs, cosmetics, and related technologies, optimizing IP portfolios for growth.

• Advances in cell research, exosome technology, and functional ingredients underpin new product development.